Piclidenoson Withdrawn Phase 2 Trials for Uveitis, Intermediate / Chorioretinitis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01905124Safety &Efficacy of CF101 to Subjects With Uveitis